Cervical Cancer Screening Challenges

Cervical cancer is one of the most common cancers among women all over the world. Most cases of cervical cancer occur in countries with limited resources. Screening in areas with rich facilities in people with moderate risk is done with cytology every three years, an HPV test, or both together (co-test) every five years. Screening starts at the age of 21 and ends at the age of 65, provided that the screening is sufficient and normal. In HIV-positive and immunocompromised people, at first visit cytology and colposcopy are performed, and then cytology is done every year; if it is negative three times, it continues every three years. In areas with limited facilities, it is recommended to start screening at the age of 30 for most cases, and depending on the test used, repeat the test every 3–10 years. If two consecutive screening results are negative, screening can be stopped at age 50.

Authors

Institutions

Publication Details

Journal
Journal of Obstetrics Gynecology and Cancer Research
Published
2025-08-03
DOI
https://doi.org/10.24200/jogcr.10.9.660
Primary Topic
Cervical Cancer and HPV Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Cervical Cancer Screening Challenges

Somayyeh Noei Teymoordash, Maliheh Arab, Maryam Motamedinasab, Akram Ghahghaei‐Nezamabadi et al.
Journal of Obstetrics Gynecology and Cancer Research
Cervical Cancer and HPV Research
article

Cervical Cancer Screening Challenges

Somayyeh Noei Teymoordash, Maliheh Arab, Maryam Motamedinasab, Akram Ghahghaei‐Nezamabadi, Hamid Reza Dehghan Manshadi, N. Nouri
article en

Abstract

Cervical cancer is one of the most common cancers among women all over the world. Most cases of cervical cancer occur in countries with limited resources. Screening in areas with rich facilities in people with moderate risk is done with cytology every three years, an HPV test, or both together (co-test) every five years. Screening starts at the age of 21 and ends at the age of 65, provided that the screening is sufficient and normal. In HIV-positive and immunocompromised people, at first visit cytology and colposcopy are performed, and then cytology is done every year; if it is negative three times, it continues every three years. In areas with limited facilities, it is recommended to start screening at the age of 30 for most cases, and depending on the test used, repeat the test every 3–10 years. If two consecutive screening results are negative, screening can be stopped at age 50.

Journal of Obstetrics Gynecology and Cancer ResearchVol. 10(9)
Iran University of Medical Sciences (IR), Shahid Beheshti University of Medical Sciences (IR), Tehran University of Medical Sciences (IR)
Openalex Percentile: Top 71%
Cervical Cancer and HPV Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.